Shortage reports
Actual shortage:
283 (9%)
Anticipated shortage:
1 (0%)
Avoided shortage:
10 (0%)
Resolved:
2953 (91%)
3247
Discontinuation Reports
To be discontinued:
2 (0%)
Discontinued:
410 (94%)
Reversed:
23 (5%)
435
483 (13%)
16 (6%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-BUDESONIDE | 0.125MG | SUSPENSION | Resolved | 2024-08-08 | 2025-12-13 | 234891 |
| TEVA-BUDESONIDE | 0.5MG | SUSPENSION | Resolved | 2020-01-09 | 2020-03-05 | 102923 |
| TEVA-BUDESONIDE | 0.125MG | SUSPENSION | Resolved | 2021-06-03 | 2021-10-14 | 140390 |
| TEVA-BUDESONIDE | 0.5MG | SUSPENSION | Resolved | 2023-06-19 | 2025-12-02 | 195478 |
| TEVA-BUDESONIDE | 0.125MG | SUSPENSION | Resolved | 2023-06-20 | 2023-07-06 | 195815 |
| TEVA-BUDESONIDE | 0.125MG | SUSPENSION | Resolved | 2023-11-03 | 2024-01-19 | 209145 |
| TEVA-BUDESONIDE | 0.5MG | SUSPENSION | Resolved | 2019-09-05 | 2019-12-19 | 93131 |
| TEVA-BUDESONIDE | 0.125MG | SUSPENSION | Resolved | 2022-08-18 | 2023-10-06 | 167197 |
| TEVA-BUDESONIDE | 0.5MG | SUSPENSION | Resolved | 2022-08-18 | 2023-07-05 | 167156 |
| TEVA-BUDESONIDE | 0.5MG | SUSPENSION | Resolved | 2022-05-19 | 2022-06-09 | 160994 |
| TEVA-BUPRENORPHINE/NALOXONE | 8MG 2MG | TABLET | Actual shortage | 2025-08-29 | 2025-10-30 | 266199 |
| TEVA-BUPRENORPHINE/NALOXONE | 0.5MG 2MG | TABLET | Resolved | 2021-08-27 | 2021-09-16 | 144704 |
| TEVA-BUPRENORPHINE/NALOXONE | 2MG 8MG | TABLET | Resolved | 2022-12-01 | 2022-12-22 | 176824 |
| TEVA-BUPRENORPHINE/NALOXONE | 2MG 0.5MG | TABLET | Resolved | 2021-05-20 | 2021-06-03 | 139725 |
| TEVA-BUPRENORPHINE/NALOXONE | 2MG 0.5MG | TABLET | Actual shortage | 2025-08-29 | 2025-10-30 | 266196 |
| TEVA-BUPRENORPHINE/NALOXONE | 2MG 0.5MG | TABLET | Resolved | 2021-06-03 | 2021-06-10 | 140363 |
| TEVA-BUPRENORPHINE/NALOXONE | 2MG 0.5MG | TABLET | Resolved | 2024-03-07 | 2024-06-27 | 221534 |
| TEVA-BUPRENORPHINE/NALOXONE | 2MG 8MG | TABLET | Resolved | 2024-03-07 | 2024-06-27 | 221537 |
| TEVA-BUPRENORPHINE/NALOXONE | 2MG 0.5MG | TABLET | Resolved | 2022-08-18 | 2022-12-02 | 167203 |
| TEVA-BUPROPION XL | 300MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-11-09 | 2023-12-07 | 209672 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-ACYCLOVIR | 200MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256122 |
| TEVA-ACYCLOVIR | 400MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256125 |
| TEVA-ACYCLOVIR | 800MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256128 |
| TEVA-ALMOTRIPTAN | 12.5MG | TABLET | Discontinued | 2025-06-17 | 2025-06-17 | 260543 |
| TEVA-AMITRIPTYLINE | 25MG | TABLET | Discontinued | 2022-01-07 | 2022-01-07 | 152351 |
| TEVA-AMITRIPTYLINE | 50MG | TABLET | Discontinued | 2020-10-22 | 2020-10-24 | 126900 |
| TEVA-AMITRIPTYLINE | 10MG | TABLET | Discontinued | 2020-09-24 | 2020-09-24 | 124896 |
| TEVA-AMITRIPTYLINE | 10MG | TABLET | Discontinued | 2020-10-22 | 2020-10-24 | 126903 |
| TEVA-AMITRIPTYLINE | 25MG | TABLET | Discontinued | 2022-01-07 | 2022-01-07 | 152375 |
| TEVA-AMITRIPTYLINE | 50MG | TABLET | Discontinued | 2022-01-07 | 2022-01-07 | 152378 |
| TEVA-AMLODIPINE | 5MG | TABLET | Reversed | 2025-05-28 | 2025-06-04 | 258670 |
| TEVA-AMLODIPINE | 10MG | TABLET | Discontinued | 2020-07-10 | 2020-07-10 | 120039 |
| TEVA-AMLODIPINE | 5MG | TABLET | Discontinued | 2020-07-10 | 2020-07-10 | 120036 |
| TEVA-AMLODIPINE | 10MG | TABLET | Reversed | 2025-05-28 | 2025-06-04 | 258667 |
| TEVA-ARIPIPRAZOLE | 15MG | TABLET | Discontinued | 2020-06-11 | 2020-06-11 | 117538 |
| TEVA-ARIPIPRAZOLE | 2MG | TABLET | Discontinued | 2020-05-14 | 2020-05-14 | 115085 |
| TEVA-ARIPIPRAZOLE | 20MG | TABLET | Discontinued | 2019-10-25 | 2019-10-26 | 97267 |
| TEVA-ARIPIPRAZOLE | 30MG | TABLET | Discontinued | 2020-06-11 | 2020-06-11 | 117541 |
| TEVA-ARIPIPRAZOLE | 5MG | TABLET | Discontinued | 2020-01-24 | 2020-01-24 | 104283 |
| TEVA-ARIPIPRAZOLE | 15MG | TABLET | Discontinued | 2019-10-25 | 2019-10-26 | 97264 |